FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.0  |  FHIR Version n/a  User: [n/a]

19374011000001106: Bazuka Extra Strength Treatment 26% gel (Diomed Developments Ltd) 6 gram (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 24-Aug 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1969581000001116 Bazuka Extra Strength Treatment 26% gel (Dermal Laboratories Ltd) 6 gram en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
1969591000001119 Bazuka Extra Strength Treatment 26% gel (Dermal Laboratories Ltd) 6 gram (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
2167901000001110 Bazuka Extra Strength Treatment 26% gel (Diomed Developments Ltd) 6 gram en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2167921000001115 Bazuka Extra Strength Treatment 26% gel (Diomed Developments Ltd) 6 gram (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
65354901000001114 Bazuka Extra Strength Treatment 26% gel (Dendron Ltd) 6 gram (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
65355001000001114 Bazuka Extra Strength Treatment 26% gel (Dendron Ltd) 6 gram en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bazuka Extra Strength Treatment 26% gel (Diomed Developments Ltd) 6 gram Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Bazuka Extra Strength Treatment 26% gel (Diomed Developments Ltd) 6 gram Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Bazuka Extra Strength Treatment 26% gel (Diomed Developments Ltd) 6 gram Is a Salicylic acid 26% gel 6 gram true Inferred relationship Existential restriction modifier
Bazuka Extra Strength Treatment 26% gel (Diomed Developments Ltd) 6 gram Has AMP Bazuka Extra Strength Treatment 26% gel (Diomed Developments Ltd) true Inferred relationship Existential restriction modifier
Bazuka Extra Strength Treatment 26% gel (Diomed Developments Ltd) 6 gram Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Bazuka Extra Strength Treatment 26% gel (Diomed Developments Ltd) 6 gram VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Bazuka Extra Strength Treatment 26% gel (Diomed Developments Ltd) 6 gram VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Bazuka Extra Strength Treatment 26% gel (Diomed Developments Ltd) 6 gram Has specific active ingredient Salicylic acid true Inferred relationship Existential restriction modifier
Bazuka Extra Strength Treatment 26% gel (Diomed Developments Ltd) 6 gram Has dispensed dose form Gel true Inferred relationship Existential restriction modifier
Bazuka Extra Strength Treatment 26% gel (Diomed Developments Ltd) 6 gram Legal category General sales list true Inferred relationship Existential restriction modifier
Bazuka Extra Strength Treatment 26% gel (Diomed Developments Ltd) 6 gram Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Bazuka Extra Strength Treatment 26% gel (Diomed Developments Ltd) 6 gram Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start